13F HOLDINGS REPORT
Birchview Capital, LP
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0001618205-23-000005
Total Value
$117.5M
Positions
52
Other Managers
0
Confidential Omitted
No
Holdings (52)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BRISTOL-MYERS SQUIBB CO | CELG-RI | 716,297 | $41.6M | 35.38% |
| 2 | NEUROCRINE BIOSCIENCES INC | NBIX | 77,240 | $8.7M | 7.40% |
| 3 | BIODESIX INC | BDSX | 5,039,633 | $8.3M | 7.08% |
| 4 | PROTHENA CORP PLC | PRTA | 169,574 | $8.2M | 6.96% |
| 5 | ACADIA PHARMACEUTICALS INC | ACAD | 240,400 | $5.0M | 4.26% |
| 6 | QUIDELORTHO CORP | QDEL | 65,203 | $4.8M | 4.05% |
| 7 | OVINTIV INC | OVV | 84,200 | $4.0M | 3.41% |
| 8 | IMMUNOGEN INC | 45253H101 | 190,000 | $3.0M | 2.57% |
| 9 | UNITED THERAPEUTICS CORP | UTHR | 11,000 | $2.5M | 2.11% |
| 10 | ELUTIA INC | ELUT | 1,655,184 | $2.4M | 2.01% |
| 11 | HARROW HEALTH INC | HROW | 150,000 | $2.2M | 1.83% |
| 12 | PHREESIA INC | PHR | 82,700 | $1.5M | 1.31% |
| 13 | ALKERMES PLC | ALKS | 50,000 | $1.4M | 1.19% |
| 14 | BLUEBIRD BIO INC | 09609G100 | 455,200 | $1.4M | 1.18% |
| 15 | CORCEPT THERAPEUTICS INC | CORT | 50,000 | $1.4M | 1.16% |
| 16 | MASIMO CORP | MASI | 15,280 | $1.3M | 1.14% |
| 17 | FOGHORN THERAPEUTICS INC | FHTX | 264,843 | $1.3M | 1.13% |
| 18 | ACCELERATE DIAGNOSTICS INC | 00430H102 | 225,239 | $1.3M | 1.10% |
| 19 | INHIBRX INC | INBX | 70,448 | $1.3M | 1.10% |
| 20 | EQUITRANS MIDSTREAM CORPORATIO | 294600101 | 133,050 | $1.2M | 1.06% |
| 21 | ALPHATEC HOLDINGS INC | ATEC | 80,000 | $1.0M | 0.88% |
| 22 | VENTYX BIOSCIENCES INC | 92332V107 | 26,400 | $916,872 | 0.78% |
| 23 | PIONEER NATURAL RESOURCES CO | 723787107 | 3,800 | $872,290 | 0.74% |
| 24 | 10X GENOMICS INC | TXG | 21,000 | $866,250 | 0.74% |
| 25 | AXOGEN INC | AXGN | 173,000 | $865,000 | 0.74% |
| 26 | KARYOPHARM THERAPEUTICS INC | KPTI | 571,832 | $766,255 | 0.65% |
| 27 | CYTOKINETICS INC | CYTK | 25,000 | $736,500 | 0.63% |
| 28 | TRAVERE THERAPEUTICS INC | TVTX | 82,000 | $733,080 | 0.62% |
| 29 | DOCGO INC | DCGO | 130,000 | $692,900 | 0.59% |
| 30 | APELLIS PHARMACEUTICALS INC | APLS | 18,000 | $684,720 | 0.58% |
| 31 | PROTAGONIST THERAPEUTICS INC | PTGX | 38,000 | $633,840 | 0.54% |
| 32 | SILK ROAD MEDICAL INC | 82710M100 | 41,294 | $618,997 | 0.53% |
| 33 | PROGYNY INC | PGNY | 18,000 | $612,360 | 0.52% |
| 34 | KINIKSA PHARMACEUTICALS LTD | KNSA | 30,000 | $521,100 | 0.44% |
| 35 | KALVISTA PHARMACEUTICALS INC | KALV | 40,000 | $385,200 | 0.33% |
| 36 | HALOZYME THERAPEUTICS INC | HALO | 10,000 | $382,000 | 0.33% |
| 37 | XENON PHARMACEUTICALS INC | XENE | 10,000 | $341,600 | 0.29% |
| 38 | AMICUS THERAPEUTICS INC | FOLD | 28,000 | $340,480 | 0.29% |
| 39 | STOKE THERAPEUTICS INC | STOK | 85,000 | $334,900 | 0.29% |
| 40 | SAREPTA THERAPEUTICS INC | SRPT | 2,500 | $303,050 | 0.26% |
| 41 | ARVINAS INC | ARVN | 15,000 | $294,600 | 0.25% |
| 42 | XENCOR INC | XNCR | 12,300 | $247,845 | 0.21% |
| 43 | 2SEVENTY BIO INC | 901384107 | 59,833 | $234,545 | 0.20% |
| 44 | CULLINAN ONCOLOGY INC | CGEM | 25,114 | $227,282 | 0.19% |
| 45 | KEROS THERAPEUTICS INC | KROS | 7,000 | $223,160 | 0.19% |
| 46 | BIODESIX INC COM RST | BDSX | 153,703 | $211,765 | 0.18% |
| 47 | GOSSAMER BIO INC | GOSS | 209,088 | $174,128 | 0.15% |
| 48 | G1 THERAPEUTICS INC | 3621LQ109 | 120,000 | $172,800 | 0.15% |
| 49 | INFLARX NV | IFRX | 50,000 | $149,000 | 0.13% |
| 50 | BIOCRYST PHARMACEUTICALS INC | BCRX | 20,000 | $141,600 | 0.12% |
| 51 | NEKTAR THERAPEUTICS | NKTR | 28,000 | $16,677 | 0.01% |
| 52 | YIELD10 BIOSCIENCE INC | 98585K102 | 18,750 | $6,126 | 0.01% |